2018 Conference EEG Biomarkers

Drs. Craig Erickson and Devin Binder present recent EEG data, including treatment data, in both patients with Fragile X syndrome and in mouse models of the disease.

The congruence of certain EEG findings across humans and mice stimulates the goal of validation of EEG parameters as translational biomarkers for treatment development. In this video presentation, Erickson and Binder summarize recent findings, current and ongoing efforts, and the future direction for this work, which they hope will lead to more objective, measurable parameters to quantify treatment effects on brain circuits in Fragile X syndrome.